# DnaNudge

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dnanudge

- Industry: Consumer Products
- Headquarters: London, UK
- Website: www.dnanudge.com
- Total disclosed funding: $60M
- Latest round: Series A (Aug 18, 2021)
- Investors on record: 2

## About

Based in London, UK, and founded in 2015, DnaNudge Limited provides a lifestyle platform solution that uses DNAs to shop. The company was co-founded by Professor Chris Toumazou and Dr. Maria Karvela. In August 2021, the company raised its latest Series A funding led by Ventura Capital.

The company is focused on genetics testing and medical diagnostics. The DnaNudge Nutrition service analyses and maps users’ genetic profiles to key nutrition-related health traits such as obesity, diabetes, hypertension, and cholesterol, enabling customers to be guided by their DNA towards healthier eating. The company is also providing CovidNudge testing as a private consumer service and is playing a key role in the safe return of the UK’s cultural sector.

The company generates revenue by selling its products on its online store. The company charged GBP 120 for its Nutrition Package, GBP 100 for the COVID Bubble home test kit, and GBP 10 for Accessories.

The company plans to accelerate the deployment of its rapid genetic testing solutions, including the sample-to-result RT-PCR COVID-19 test CovidNudge.

## Funding rounds

- Series A, Aug 18, 2021, $60M — Julius Baer, Ventura Capital

## Investors

- Julius Baer (https://capitalatlas.ai/funds/julius-baer) — Series A
- Ventura Capital (https://capitalatlas.ai/funds/ventura-capital) — Series A